Skip to main content

Octreotide vs AOD-9604 & CJC-1295 & Ipamorelin (Stack)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Octreotide

Octreotide (Sandostatin) is a synthetic somatostatin analog FDA-approved for acromegaly, carcinoid tumors, and VIPomas. It inhibits growth hormone and various GI hormones.

Full details →

AOD-9604 & CJC-1295 & Ipamorelin (Stack)

A targeted fat loss stack combining AOD-9604 (the fat-burning fragment of HGH) with CJC-1295 and Ipamorelin for comprehensive body recomposition. This blend addresses fat loss directly while supporting lean mass through GH optimization.

Full details →

Side-by-Side Comparison

AspectOctreotideAOD-9604 & CJC-1295 & Ipamorelin (Stack)
MechanismBinds to somatostatin receptors (primarily SSTR2 and SSTR5) to inhibit GH, glucagon, insulin, and gastric secretions. Reduces blood flow to GI tract and inhibits tumor hormone secretion.AOD-9604 stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or blood glucose. CJC-1295 and Ipamorelin provide sustained and pulsatile GH release to support metabolism and lean tissue. The combination targets fat loss through multiple mechanisms while preserving muscle.
Typical DosageVaries by indication. Acromegaly: 50-100mcg three times daily initially, up to 500mcg TID. LAR (long-acting): 20-30mg IM every 4 weeks.Typical protocol: AOD-9604 200-400mcg, CJC-1295 100-200mcg, Ipamorelin 100-200mcg daily. Usually administered in the morning fasted or before exercise.
AdministrationSubcutaneous injection for immediate-release (between meals). Intramuscular for LAR depot form. Requires monitoring of gallbladder, glucose, and thyroid.Subcutaneous injection. Best administered fasted to maximize fat-burning effects. Can be taken as a pre-mixed blend or separate injections. Cycles typically run 8-16 weeks.
Side EffectsGI effects (diarrhea, nausea, abdominal pain), gallstones (up to 25% of long-term users), injection site reactions, and blood glucose changes.Mild injection site reactions, headache, nausea. Generally well-tolerated as AOD-9604 lacks many HGH side effects.
Best For

Key Differences

Unique to Octreotide:

Unique to AOD-9604 & CJC-1295 & Ipamorelin (Stack):

Ready to Learn More?